康臣藥業(01681.HK)在新疆霍爾果斯設立全資附屬康臣藥業(霍爾果斯)
格隆匯8月17日丨康臣藥業(01681.HK)發佈公吿,為響應國家建設新疆,打造霍爾果斯一帶一路歐亞大陸橋頭堡口岸的戰略,及應對當前國內醫藥市場、政策等複雜多變環境的挑戰,公司全資附屬公司康臣藥業(內蒙古)有限責任公司基於前期對新疆霍爾果斯經濟開發區進行的實地考察及調研論證,在新疆霍爾果斯設立了全資附屬公司康臣藥業(霍爾果斯)有限公司。
在中國的西北部設立公司並建設生產基地,可提升、完善和優化集團產業基地的佈局,加強了西北各省的產品覆蓋,減少運輸半徑,形成覆蓋全國的、均勻的生產基地格局,同時也可充分利用西北地區中藥材品種多,數量大等優勢就地採購,而國家和霍爾果斯在商貿物流產業上的大力發展,也為邊疆地區交通、物流效率問題的解決提供了有力支撐。
除了以上因素外,根據國家有關部門對新疆霍爾果斯特殊經濟開發區的系列優惠政策,康臣藥業(霍爾果斯)有限公司可享受包括税收優惠政策在內的各項扶持,這有利於康臣藥業(霍爾果斯)有限公司未來五至十年的發展,並對其利潤的回報產生明顯的效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.